HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Francis, J. W. Articles by Fishman, P. S. Search for Related Content PubMed PubMed Citation Articles by Francis, J. W. Articles by Fishman, P. S. Social Bookmarking                      What's this?

Volume 270, Number 25, Issue of June 23, pp. 15434-15442, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Jonathan W. Francis , Betsy A. Hosler , Robert H. BrownJr. , Paul S. Fishman

Increased levels of CuZn superoxide dismutase (SOD-1) are cytoprotective in experimental models of neurological disorders associated with free radical toxicity (e.g. stroke, trauma). Targeted delivery of SOD-1 to central nervous system neurons may therefore be therapeutic in such diseases. The nontoxic C-fragment of tetanus toxin (TTC) possesses the nerve cell binding/transport properties of tetanus holotoxin and has been used as a vector to enhance the neuronal uptake of proteins including enzymes. We have now produced a recombinant, hybrid protein in Escherichia coli tandemly joining human SOD-1 to TTC. The expressed hybrid protein (SOD:Tet451) has a subunit molecular mass of 68 kDa and is recognized by both anti-SOD-1 and anti-TTC antibodies. Calculated per mol, SOD:Tet451 has approximately 60% of the expected SOD-1 enzymatic activity. Analysis of the hybrid protein's interaction with the neuron-like cell line, N18-RE-105, and cultured hippocampal neurons by enzyme immunoassay for human SOD-1 revealed that SOD:Tet451 association with cells was neuron-specific and dose-dependent. The hybrid protein was also internalized, but there was substantial loss of internalized hybrid protein over the first 24 h. Hybrid protein associated with cells remained enzymatically active. These results suggest that human SOD-1 and TTC retain their respective functional properties when expressed together as a single peptide. SOD:Tet451 may prove to be a useful agent for the targeted delivery of SOD-1 to neurons.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				W. J. Broom, K. E. Auwarter, J. Ni, D. E. Russel, L.-A. Yeh, M. M. Maxwell, M. Glicksman, A. G. Kazantsev, and R. H. Brown Jr Two Approaches to Drug Discovery in SOD1-Mediated ALS J Biomol Screen, October 1, 2006; 11(7): 729 - 735. [Abstract] [PDF]

				A. M. Payne, Z. Zheng, M. L. Messi, C. E. Milligan, E. Gonzalez, and O. Delbono Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle J. Physiol., January 15, 2006; 570(2): 283 - 294. [Abstract] [Full Text] [PDF]

				G. Schiavo, M. Matteoli, and C. Montecucco Neurotoxins Affecting Neuroexocytosis Physiol Rev, April 1, 2000; 80(2): 717 - 766. [Abstract] [Full Text] [PDF]

				L. Coen, R. Osta, M. Maury, and P. Brulet Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system PNAS, August 19, 1997; 94(17): 9400 - 9405. [Abstract] [Full Text] [PDF]

				Y. Li, P. Foran, G. Lawrence, N. Mohammed, C.-K.-N. Chan-Kwo-Chion, G. Lisk, R. Aoki, and O. Dolly Recombinant Forms of Tetanus Toxin Engineered for Examining and Exploiting Neuronal Trafficking Pathways J. Biol. Chem., August 10, 2001; 276(33): 31394 - 31401. [Abstract] [Full Text] [PDF]